| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom
In this work, we report the cloning of the cDNA for the porcine analogue of human CD59. Degenerate primers, derived from the N-terminal sequence of pig erythrocyte CD59, were used to obtain the corresponding cDNA sequence. From this sequence, gene-specific primers were designed and used to amplify the 3' and 5' ends of the cDNA using the rapid amplification of cDNA ends (RACE) method. The complete 768-bp cDNA so obtained consisted of a 84-bp 5' untranslated region, a 26-amino-acid NH2-signal peptide, a 98-amino-acid coding region, including putative N-glycosylation sites and a glycosylphosphatidylinositol-anchoring signal, and a 312-bp 3' untranslated region. The mature protein sequence was 48% identical to human CD59 at the amino acid level. Northern blot analysis revealed several distinct CD59 transcripts, and a variability in expression levels of the different transcripts in the panel of tissues screened. Stable expression of pig CD59 in a CD59-negative human cell line conferred protection against lysis by complement from pig and several other species. Separate expression of pig and human CD59 at similar levels in the same cell line allowed a direct functional comparison between these two analogues. Pig CD59 and human CD59 showed similar activity in inhibiting lysis by complement from all species tested; in particular, expressed pig CD59 efficiently inhibited lysis by human complement. The relevance of these data to current work in the engineering of pig organs for xenotransplantation is discussed.
This article has been cited by other articles:
|
|
 |
|
  C. Kobayashi, K. Matsunami, T. Omori, S. Nakatsu, K. Nakahata, H. Xu, R. Shirakura, M. Fukuzawa, and S. Miyagawa Features of a Newly Cloned Pig C1 Esterase Inhibitor J. Biochem., September 1, 2006; 140(3): 421 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Dufour, M. Hamilton, R. V. Rajotte, and G. S. Korbutt Neonatal Porcine Sertoli Cells Inhibit Human Natural Antibody-Mediated Lysis Biol Reprod, May 1, 2005; 72(5): 1224 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. van Beek, M. van Meurs, B. A. 't Hart, H. P. M. Brok, J. W. Neal, A. Chatagner, C. L. Harris, N. Omidvar, B. P. Morgan, J. D. Laman, et al. Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation J. Immunol., February 15, 2005; 174(4): 2353 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cascalho, B. M. Ogle, and J. L. Platt Xenotransplantation and the Future of Renal Replacement J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1106 - 1112. [Full Text] [PDF]
|
|
|
|
|
|
E. LeBouder, J. E. Rey-Nores, N. K. Rushmere, M. Grigorov, S. D. Lawn, M. Affolter, G. E. Griffin, P. Ferrara, E. J. Schiffrin, B. P. Morgan, et al. Soluble Forms of Toll-Like Receptor (TLR)2 Capable of Modulating TLR2 Signaling Are Present in Human Plasma and Breast Milk J. Immunol., December 15, 2003; 171(12): 6680 - 6689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-M. Qian, X. Qin, T. Miwa, X. Sun, J. A. Halperin, and W.-C. Song Identification and Functional Characterization of a New Gene Encoding the Mouse Terminal Complement Inhibitor CD59 J. Immunol., September 1, 2000; 165(5): 2528 - 2534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Perez de la Lastra, C. L. Harris, S. J. Hinchliffe, D. S. Holt, N. K. Rushmere, and B. P. Morgan Pigs Express Multiple Forms of Decay-Accelerating Factor (CD55), All of Which Contain Only Three Short Consensus Repeats J. Immunol., September 1, 2000; 165(5): 2563 - 2573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Dalmasso, B. A. Benson, J. S. Johnson, C. Lancto, and M. S. Abrahamsen Resistance Against the Membrane Attack Complex of Complement Induced in Porcine Endothelial Cells with a Gal{alpha}(1-3)Gal Binding Lectin: Up-Regulation of CD59 Expression J. Immunol., April 1, 2000; 164(7): 3764 - 3773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-f. Zhang, J. Yu, S. Chen, B. P. Morgan, R. Abagyan, and S. Tomlinson Identification of the Individual Residues That Determine Human CD59 Species Selective Activity J. Biol. Chem., April 16, 1999; 274(16): 10969 - 10974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Basta, S. M. Knoetig, M. Spagnuolo-Weaver, G. Allan, and K. C. McCullough Modulation of Monocytic Cell Activity and Virus Susceptibility During Differentiation into Macrophages J. Immunol., April 1, 1999; 162(7): 3961 - 3969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Sun, C. D. Funk, C. Deng, A. Sahu, J. D. Lambris, and W.-C. Song Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting PNAS, January 19, 1999; 96(2): 628 - 633. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
